Lemon Bottle - 10ml
Lemon Bottle - 10ml - Image 2

Lemon Bottle – 10ml

$49.00

All products are for laboratory research purposes only. Not for human consumption, medical, or veterinary use. ION Peptides does not condone or support the use of peptides outside of controlled scientific research. By purchasing, you acknowledge that you are a qualified researcher or institution. You must be 21 or older.

Only 22 left in stock

Money Back Guarantee Guaranteed Quality Customer Support Fast Shipping
Category:

Description

Lemon Bottle Mesotherapy Formula

Research-Grade Fat Dissolver Blend
Tagline: Localized Lipolysis Research Compound

Product Description

Lemon Bottle (sometimes marketed as a peptide / mesotherapy blend) is a localized injectable solution formulated for aesthetic fat-reduction research. It typically includes a mixture of enzymes, vitamins, and lipid-modulating agents (e.g. bromelain, lecithin, riboflavin) aimed at promoting adipocyte breakdown and tissue remodeling in specified areas.

Researchers may use Lemon Bottle to explore adipocyte apoptosis, lipolysis signaling, inflammation modulation, and tissue repair. Because its mechanism is largely unverified in rigorous scientific literature, it should be treated as a novel, exploratory reagent.

For Laboratory and Scientific Research Use Only. Not for Human or Veterinary Use.

Why Researchers Might Explore Lemon Bottle

  • Local Fat Dissolution Mode: Designed for targeted subcutaneous fat reduction.

  • Blend Formula: Combines enzyme, vitamin, and lipid-active compounds for multi-pathway effects.

  • Mesotherapy Model: Useful in research of injectable, localized adipose therapies.

  • Adjunct in Contouring Studies: May assist studies combining fat reduction with remodeling.

  • Novel Mechanism Exploration: Potential to uncover new adipose metabolism pathways.

Research Data & Handling Tips

  • Reconstitution / Formulation: Usually supplied as a ready-to-use sterile liquid (e.g. 10 mL vial)

  • Solubility / Composition: Mixture of water-soluble ingredients including enzymes, vitamins, lecithin, etc.

  • Storage: Store vials refrigerated (2–8 °C). Do not freeze.

  • Stability: Limited documented shelf-life; treat as per supplier guidelines (often months under refrigeration).

  • Handling Precautions: Use sterile technique; avoid contamination; protect from light exposure.

Important Note

For laboratory and scientific research only. Not for human consumption, diagnostic, or therapeutic use.

Details

Formulation Type Ready-to-use mesotherapy injectable solution
Volume / Vial Size 10 mL
Key Constituents (reported) Bromelain, Lecithin, Riboflavin (Vitamin B2), natural lipid-modulators
Appearance Clear to light yellow aqueous liquid
Intended Research Use Localized adipose tissue / mesotherapy research only
Storage Conditions Refrigerated (2–8 °C), protect from light
Handling Sterile technique, do not freeze, avoid prolonged light exposure
Supplier Claims Synergistic formulation for enhanced lipolysis and contouring

Research

Research Applications

Localized Fat Reduction

Lemon Bottle is studied as part of injectable adipolysis research, where compounds such as deoxycholic acid analogues cause adipocyte lysis and reduction of localized fat deposits. Preclinical and clinical studies on injectable fat-dissolving agents show that adipocytolysis leads to reduced fat volume and remodeling of subcutaneous tissue [Walker 2022].

Body Contouring & Subcutaneous Remodeling

The breakdown of adipocytes is followed by an inflammatory cascade and fibroblast activity, which remodels tissue in the treated area. Research on ATX-101 (a deoxycholic acid injectable) has demonstrated measurable reductions in submental fat and improved contour, making it a relevant comparative model for Lemon Bottle formulations [Rzany 2014].

Metabolic Pathways & Lipid Oxidation

Some Lemon Bottle formulations list riboflavin (Vitamin B2), which plays a role in mitochondrial energy metabolism. Riboflavin-dependent enzymes are essential for fatty acid oxidation, making it a plausible contributor to enhanced clearance of lipids released after adipocytolysis [Powers 2003].

Inflammation & Tissue Healing

Enzymatic components such as bromelain are investigated for their anti-inflammatory and proteolytic actions. These may support tissue recovery and reduce post-injection inflammation by modulating cytokine activity and aiding extracellular matrix remodeling [Maurer 2001].

References

  1. Walker P, et al. (2022). Injectable treatments for localized fat reduction: mechanisms and outcomes. Frontiers in Endocrinology.
    https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.841889/full

  2. Rzany B, et al. (2014). ATX-101 for reduction of submental fat: mechanism and clinical data. British Journal of Dermatology.
    https://academic.oup.com/bjd/article/170/2/445/6614988

  3. Walker PS, Hexsel D. (2014). Injection adipolysis: mechanisms, agents, and future directions. Journal of Clinical and Aesthetic Dermatology.
    https://jcadonline.com/injection-adipolysis-mechanisms-agents-and-future-directions/

  4. Maurer HR (2001). Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci.
    https://link.springer.com/article/10.1007/PL00000936

Mechanism of Action

Mechanism of Action (How Lemon Bottle Works)

  • Adipocytolysis: Active components (e.g., deoxycholic acid analogues) disrupt adipocyte membranes, causing fat cell lysis and release of stored triglycerides [Walker 2022].

  • Lipid Clearance Pathway: Released lipids are metabolized and cleared via macrophage recruitment and lymphatic transport [Rzany 2014].

  • Inflammatory Cascade & Remodeling: Adipocyte death induces local inflammation, followed by fibroblast activity and tissue remodeling [Rzany 2014].

  • Metabolic Cofactor Action: Reported components like riboflavin (Vitamin B2) may enhance fatty acid oxidation pathways [Frontiers in Endocrinology 2022].

  • Enzymatic Support: Proteolytic enzymes (e.g., bromelain) are known to reduce inflammation and promote extracellular matrix remodeling in injury/tissue models [Maurer 2001].

References

  1. Walker P, et al. (2022). Injectable treatments for localized fat reduction: mechanisms and outcomes. Frontiers in Endocrinology.
    https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.841889/full

  2. Rzany B, et al. (2014). ATX-101 for reduction of submental fat: mechanism and clinical data. British Journal of Dermatology.
    https://academic.oup.com/bjd/article/170/2/445/6614988

  3. Walker PS, Hexsel D. (2014). Injection adipolysis: mechanisms, agents, and future directions. Journal of Clinical and Aesthetic Dermatology.
    https://jcadonline.com/injection-adipolysis-mechanisms-agents-and-future-directions/

  4. Maurer HR (2001). Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci.
    https://link.springer.com/article/10.1007/PL00000936

Related products